Cardiovascular and gastrointestinal events of three antiplatelet therapies: clopidogrel, clopidogrel plus proton-pump inhibitors, and aspirin plus proton-pump inhibitors in patients with previous gastrointestinal bleeding.
BACKGROUND
Concomitant use of antiplatelet agents and proton-pump inhibitors (PPIs) has been recommended in patients with a history of gastrointestinal (GI) hemorrhage. However, recent studies have reported that PPIs may alter clopidogrel's pharmacokinetics and potentially lead to an increased risk of recurrent adverse cardiovascular (CV) events.


METHODS
Using Taiwan's 2000-2006 National Health Insurance database, this population-based retrospective cohort study assessed CV and GI events in patients who had a prior history of GI bleeding and had been prescribed ongoing antiplatelet therapy after acute coronary syndrome (ACS) discharge. We identified 3,580 ACS patients and categorized them into (1) those taking clopidogrel alone, (2) those taking clopidogrel plus PPIs, and (3) those taking aspirin plus PPIs. Cox proportional hazards models were used to assess the association between the use of antiplatelet therapies and CV/GI events.


RESULTS
The clopidogrel only group and the clopidogrel plus PPI group were found to be at lower risk for GI events than the aspirin plus PPI group [adjusted hazard ratio (HR) 0.23 (95% confidence interval; CI 0.14-0.36) and HR 0.70 (0.52-0.96), respectively]. However, while the clopidogrel only group had a lower risk of CV events than the aspirin plus PPI group [HR 0.57 (0.38-0.84)], the clopidogrel plus PPI group had a significantly higher CV risk than the aspirin plus PPI group [HR 1.59 (1.18-2.13)].


CONCLUSIONS
Our findings suggest that although the use of clopidogrel plus PPIs provides GI benefits, with this treatment, there is an increased CV risk among patients with a history of GI bleeding.
Tsai
Yi-Wen
YW
Institute of Population Health Sciences, National Health Research Institutes, Miaoli, Taiwan.
Wen
Yu-Wen
YW
Huang
Weng-Foung
WF
Chen
Pei-Fen
PF
Kuo
Ken N
KN
Hsiao
Fei-Yuan
FY
D054058:Acute Coronary Syndrome / Q000150:complications / Q000188:drug therapy; D000368:Aged; D000369:Aged, 80 and over; D001241:Aspirin / Q000008:administration & dosage / Q000009:adverse effects*; D002318:Cardiovascular Diseases / Q000150:complications / Q000188:drug therapy / Q000453:epidemiology*; D000077144:Clopidogrel; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D005260:Female; D005765:Gastrointestinal Agents / Q000008:administration & dosage / Q000009:adverse effects*; D006471:Gastrointestinal Hemorrhage / Q000139:chemically induced / Q000150:complications / Q000188:drug therapy / Q000453:epidemiology*; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D010437:Peptic Ulcer / Q000139:chemically induced / Q000150:complications / Q000188:drug therapy / Q000453:epidemiology*; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D016016:Proportional Hazards Models; D054328:Proton Pump Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D012189:Retrospective Studies; D012306:Risk; D013624:Taiwan; D013988:Ticlopidine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D016896:Treatment Outcome
D005765:Gastrointestinal Agents; D010975:Platelet Aggregation Inhibitors; D054328:Proton Pump Inhibitors; D000077144:Clopidogrel; D013988:Ticlopidine; D001241:Aspirin
Am Heart J. 2009 Jan;157(1):148.e1-5
19081411
J Am Coll Cardiol. 2008 Jan 22;51(3):261-3
18206733
Clin Gastroenterol Hepatol. 2006 Jul;4(7):860-5
16797240
Thromb Haemost. 2009 Apr;101(4):714-9
19350116
Lancet. 1996 Nov 16;348(9038):1329-39
8918275
Chest. 2004 Sep;126(3 Suppl):513S-548S
15383483
BMJ. 2002 Jan 12;324(7329):71-86
11786451
JAMA. 2009 Mar 4;301(9):937-44
19258584
N Engl J Med. 2005 Jan 20;352(3):238-44
15659723
CMAJ. 2009 Mar 31;180(7):713-8
19176635
J Clin Pharmacol. 2008 Apr;48(4):475-84
18303127
J Am Pharm Assoc (2003). 2004 Mar-Apr;44(2 Suppl 1):S5-12; quiz S12-3
15095931
JAMA. 2004 Oct 20;292(15):1867-74
15494585
Intern Med. 2009;48(19):1725-30
19797827
Circulation. 2007 Aug 14;116(7):e148-304
17679616
Clin Pharmacol Ther. 2008 Aug;84(2):236-42
18323861
J Am Coll Cardiol. 2008 Jan 22;51(3):256-60
18206732